{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:02:31Z","timestamp":1787313751243,"version":"build-2736575974"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T00:00:00Z","timestamp":1552608000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00403-019-01910-3","type":"journal-article","created":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T17:06:07Z","timestamp":1552669567000},"page":"331-335","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Mast cells in hidradenitis suppurativa: a clinicopathological study"],"prefix":"10.1007","volume":"311","author":[{"given":"Emil K.","family":"List","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8279-215X","authenticated-orcid":false,"given":"Jose C.","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kian","family":"Zarchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit M.","family":"N\u00fcrnberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor B. E.","family":"Jemec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,15]]},"reference":[{"key":"1910_CR1","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1038\/jid.2008.331","volume":"128","author":"IT Harvima","year":"2008","unstructured":"Harvima IT (2008) Induction of matrix metalloproteinase-9 in keratinocytes by histamine. J Invest Dermatol 128:2748\u20132750","journal-title":"J Invest Dermatol"},{"key":"1910_CR2","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/S0190-9622(96)90277-7","volume":"34","author":"GBE Jemec","year":"1996","unstructured":"Jemec GBE, Hansen U (1996) Histology of hidradenitis suppurativa. J Am Acad Dermatol 34:994\u2013999","journal-title":"J Am Acad Dermatol"},{"key":"1910_CR3","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/j.burns.2014.04.004","volume":"40","author":"IS Kwak","year":"2014","unstructured":"Kwak IS, Choi YH, Jang YC, Lee YK (2014) Immunohistochemical analysis of neuropeptides (protein gene product 9.5, substance P and calcitonin gene-related peptide) in hypertrophic burn scar with pain and itching. Burns 40:1661\u20131667","journal-title":"Burns"},{"key":"1910_CR4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/j.1600-0625.2009.00915.x","volume":"19","author":"M Laffert","year":"2010","unstructured":"Laffert M, Helmbold P, Wohlrab J, Fiedler E, Stadie V, Marsch WC (2010) Hidradenitis suppurativa (acne inversa): early inflammatory events at terminal follicles and at interfollicular epidermis. Exp Dermatol 19:533\u2013537","journal-title":"Exp Dermatol"},{"key":"1910_CR5","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/bjd.14214","volume":"174","author":"AL Lima","year":"2016","unstructured":"Lima AL, Karl I, Giner T, Poppe H, Schmidt M, Presser D, Goebeler M, Bauer B (2016) Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa. Br J Dermatol 174:514\u2013521","journal-title":"Br J Dermatol"},{"key":"1910_CR6","doi-asserted-by":"publisher","first-page":"490","DOI":"10.4049\/jimmunol.1100123","volume":"187","author":"AM Lin","year":"2011","unstructured":"Lin AM, Rubin CJ, Khandpur R, Wang JY, Riblett M, Yalavarthi S, Villanueva EC, Shah P, Kaplan MJ, Bruce AT (2011) Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J Immunol 187:490\u2013500","journal-title":"J Immunol"},{"key":"1910_CR7","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jaad.2016.10.042","volume":"76","author":"\u0141 Matusiak","year":"2017","unstructured":"Matusiak \u0141, Szcz\u0119ch J, Bieniek A, Nowicka-Suszko D, Szepietowski JC (2017) Increased interleukin (IL)-17 serum levels in patients with hidradenitis suppurativa: implications for treatment with anti-IL-17 agents. J Am Acad Dermatol 76:670\u2013675","journal-title":"J Am Acad Dermatol"},{"key":"1910_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.brainres.2008.05.057","volume":"1226","author":"H Michaloudi","year":"2008","unstructured":"Michaloudi H, Batzios C, Chiotelli M, Grivas I, Papadopoulos GC (2008) Mast cells populations fluctuate along the spinal dura mater of the developing rat. Brain Res 1226:8\u201317","journal-title":"Brain Res"},{"key":"1910_CR9","doi-asserted-by":"publisher","first-page":"4568","DOI":"10.4049\/jimmunol.1302593","volume":"193","author":"F Mion","year":"2014","unstructured":"Mion F, D\u2019Inc\u00e0 F, Danelli L, Toffoletto B, Guarnotta C, Frossi B, Burocchi A, Rigoni A, Gerdes N, Lutgens E, Tripodo C, Colombo MP, Rivera J, Vitale G, Pucillo CE (2014) Mast cells control the expansion and differentiation of IL-10\u2014competent B cells. J Immunol 193:4568\u20134579","journal-title":"J Immunol"},{"key":"1910_CR10","first-page":"1092","volume":"159","author":"KE Nograles","year":"2008","unstructured":"Nograles KE, Zaba LC, Guttman-Yassky E, Fuentes-Duculan J, Su\u00e1rez-Fari\u00f1as M, Cardinale I, Khatcherian A, Gonzalez J, Pierson KC, White TR, Pensabene C, Coats I, Novitskaya I, Lowes MA, Krueger JG (2008) Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br J Dermatol 159:1092\u20131102","journal-title":"Br J Dermatol"},{"key":"1910_CR11","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s40257-017-0304-y","volume":"18","author":"JC Pascual","year":"2017","unstructured":"Pascual JC, Alvarez P, Encabo B, Gonzalez I, Hispan P, Poveda I, Romero D (2017) Comment on Assessing pruritus in hidradenitis suppurativa: a cross-sectional study. Am J Clin Dermatol 18:705\u2013706","journal-title":"Am J Clin Dermatol"},{"key":"1910_CR12","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1111\/bjd.14870","volume":"175","author":"JC Pascual","year":"2016","unstructured":"Pascual JC, Garcia-Martinez FJ, Martorell A, Gonzalez I, Hispan P (2016) Increased total serum IgE in moderate-to severe hidradenitis suppurativa. Br J Dermatol 175:1101\u20131102","journal-title":"Br J Dermatol"},{"key":"1910_CR13","doi-asserted-by":"publisher","first-page":"222","DOI":"10.2340\/00015555-2129","volume":"96","author":"PT Riis","year":"2016","unstructured":"Riis PT, Vinding GR, Ring HC, Jemec GBE (2016) Disutility in patients with hidradenitis suppurativa: a cross-sectional study using EuroQoL-5D. Acta Derm 96:222\u2013226","journal-title":"Acta Derm"},{"key":"1910_CR14","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.jaad.2010.07.010","volume":"65","author":"C Schlapbach","year":"2011","unstructured":"Schlapbach C, H\u00e4nni T, Yawalkar N, Hunger RE (2011) Expression of the IL-23\/Th17 pathway in lesions of hidradenitis suppurativa. J Am Acad Dermatol 65:790\u2013798","journal-title":"J Am Acad Dermatol"},{"key":"1910_CR15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1046\/j.1365-2133.2003.05390.x","volume":"149","author":"K Sartorius","year":"2003","unstructured":"Sartorius K, Lapins J, Emtestam L, Jemec GBE (2003) Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa. Br J Dermatol 149:211\u2013213","journal-title":"Br J Dermatol"},{"key":"1910_CR16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/j.1365-2133.2011.10643.x","volume":"166","author":"HH Zee Van Der","year":"2012","unstructured":"Van Der Zee HH, De Ruiter L, Boer J, Van Den Broecke DG, Den Hollander JC, Laman JD, Prens EP (2012) Alterations in leucocyte subsets and histomorphology in normal-apperaring perilesional skin and early and chronic hidradenitis suppurativa lesions. Br J Dermatol 166:98\u2013106","journal-title":"Br J Dermatol"},{"key":"1910_CR17","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1365-2133.2011.10254.x","volume":"164","author":"HH Zee van der","year":"2017","unstructured":"van der Zee HH, de Ruiter L, van den Broecke DG, Dik WA, Laman JD, Prens EP (2017) Elevated levels of tumour necrosis factor (TNF)-\u03b1, interleukin (IL)-1\u03b2 and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-\u03b1 and IL-1\u03b2. Br J Dermatol 164:1292\u20131298","journal-title":"Br J Dermatol"},{"key":"1910_CR18","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1016\/j.jaad.2015.07.047","volume":"73","author":"HH Zee Van Der","year":"2015","unstructured":"Van Der Zee HH, Jemec GBE (2015) New insights into the diagnosis of hidradenitis suppurativa: Clinical presentations and phenotypes. J Am Acad Dermatol 73:S23\u2013S26","journal-title":"J Am Acad Dermatol"},{"key":"1910_CR19","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1365-2133.2010.10034.x","volume":"164","author":"M Laffert Von","year":"2011","unstructured":"Von Laffert M, Stadie V, Wohlrab J, Marsch WC (2011) Hidradenitis suppurativa\/acne inversa: bilocated epithelial hyperplasia with very different sequelae. Br J Dermatol 164:367\u2013371","journal-title":"Br J Dermatol"},{"key":"1910_CR20","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s40257-017-0280-2","volume":"18","author":"ARJV Vossen","year":"2017","unstructured":"Vossen ARJV, Schoenmakers A, van Straalen KR, Prens EP, van der Zee HH (2017) Assessing pruritus in hidradenitis suppurativa: a cross-sectional study. Am J Clin Dermatol 18:687\u2013695","journal-title":"Am J Clin Dermatol"},{"key":"1910_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/630128","volume":"630128","author":"U W\u00f6lfle","year":"2015","unstructured":"W\u00f6lfle U, Haarhaus B, Schempp CM (2015) Amarogentin displays immunomodulatory effects in human mast cells and keratinocytes. Mediators Inflamm 630128:1\u20138","journal-title":"Mediators Inflamm"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-019-01910-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-019-01910-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-019-01910-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T20:09:00Z","timestamp":1584130140000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-019-01910-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,15]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["1910"],"URL":"https:\/\/doi.org\/10.1007\/s00403-019-01910-3","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,15]]},"assertion":[{"value":"26 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"JCP has been an advisory board member for Abbvie. GBJ has been an investigator, consultant, and advisory board member for Abbvie, InflaRx, InCyte, Leo Pharma, Novartis and UCB; has received unrestricted grants by Abbvie, Leo Pharma and Novartis, and has been a speaker for Galderma; an advisory board member for Janssen-Cilag, Inflarx, MSD and for Pierre-Fabre; and has been an investigator for Regeneron. KZ; EKL and BMN BE, have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}